BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8887737)

  • 1. The synthesis and some pharmacological actions of the enantiomers of the K(+)-channel blocker cetiedil.
    Roxburgh CJ; Ganellin CR; Shiner MA; Benton DC; Dunn PM; Ayalew Y; Jenkinson DH
    J Pharm Pharmacol; 1996 Aug; 48(8):851-7. PubMed ID: 8887737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of cetiedil analogues as blockers of the Ca(2+)-activated K+ permeability of erythrocytes.
    Roxburgh CJ; Ganellin CR; Athmani S; Bisi A; Quaglia W; Benton DC; Shiner MA; Malik-Hall M; Haylett DG; Jenkinson DH
    J Med Chem; 2001 Sep; 44(20):3244-53. PubMed ID: 11563923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cells.
    Benton DC; Roxburgh CJ; Ganellin CR; Shiner MA; Jenkinson DH
    Br J Pharmacol; 1999 Jan; 126(1):169-78. PubMed ID: 10051133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Singer M; Russell MO; Schwartz E
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2955-9. PubMed ID: 6930678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of cetiedil and its congeners on levcromakalim-stimulated 86Rb efflux from smooth and skeletal muscle.
    Benton DC
    Eur J Pharmacol; 1996 Dec; 317(2-3):329-33. PubMed ID: 8997618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the mechanism by which cetiedil inhibits sickling.
    Abu-Salah KM; Gambo AH
    Life Sci; 2002 Jan; 70(9):1003-11. PubMed ID: 11860149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cetiedil on red cell membrane permeability.
    Schmidt WF; Asakura T; Schwartz E
    Blood Cells; 1982; 8(2):289-98. PubMed ID: 7159753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cetiedil, an in vitro antisickling agent, on erythrocyte membrane cation permeability.
    Berkowitz LR; Orringer EP
    J Clin Invest; 1981 Nov; 68(5):1215-20. PubMed ID: 7298848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.
    Berkowitz LR; Orringer EP
    Blood Cells; 1982; 8(2):283-8. PubMed ID: 7159752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of erythrocyte calcium transport by cetiedil.
    Levine SN; Berkowitz LR; Orringer EP
    Pharmacology; 1988; 36(1):44-51. PubMed ID: 2829242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cetiedil on the oxidative metabolism of activated polymorphonuclear leucocytes.
    Kohzaki H; Kakinuma K; Asakura T; Yamakawa T
    Br J Haematol; 1985 Jul; 60(3):531-9. PubMed ID: 4015989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cetiedil on cation and water movements in erythrocytes.
    Schmidt WF; Asakura T; Schwartz E
    J Clin Invest; 1982 Mar; 69(3):589-94. PubMed ID: 7061704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cetiedil inhibition of calmodulin-stimulated enzyme activity.
    Levine SN; Berkowitz LR; Orringer EP
    Biochem Pharmacol; 1984 Feb; 33(4):581-4. PubMed ID: 6231031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The action of blocking agents applied to the inner face of Ca(2+)-activated K+ channels from human erythrocytes.
    Dunn PM
    J Membr Biol; 1998 Sep; 165(2):133-43. PubMed ID: 9745001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of different types of K+ channel modulators on the spontaneous myogenic contraction of guinea-pig urinary bladder smooth muscle.
    Imai T; Okamoto T; Yamamoto Y; Tanaka H; Koike K; Shigenobu K; Tanaka Y
    Acta Physiol Scand; 2001 Nov; 173(3):323-33. PubMed ID: 11736694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compounds that block both intermediate-conductance (IK(Ca)) and small-conductance (SK(Ca)) calcium-activated potassium channels.
    Malik-Hall M; Ganellin CR; Galanakis D; Jenkinson DH
    Br J Pharmacol; 2000 Apr; 129(7):1431-8. PubMed ID: 10742299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the antigen-induced activation of RBL-2H3 cells by cetiedil and some of its analogues.
    Narenjkar J; Assem el-SK; Ganellin CR
    Eur J Pharmacol; 2004 Jan; 483(2-3):107-16. PubMed ID: 14729097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cetiedil on the superoxide-generating system of porcine neutrophils.
    Chiba T; Asakura T; Kakinuma K
    J Biochem; 1985 Aug; 98(2):355-61. PubMed ID: 2999093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bepridil and cetiedil reversibly inhibit thyroid hormone stimulation in vitro of human red cell Ca2+-ATPase activity.
    Dube MP; Davis FB; Davis PJ; Blas SD
    Mol Endocrinol; 1987 Feb; 1(2):168-71. PubMed ID: 2970587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular blocking agents inhibit receptor-mediated increases in the potassium permeability of intestinal smooth muscle.
    Gater PR; Haylett DG; Jenkinson DH
    Br J Pharmacol; 1985 Dec; 86(4):861-8. PubMed ID: 2866804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.